Richard A. Heyman, Director at Oric Pharmaceuticals, Inc. (ORIC), sold 1,388 shares at $25.03 ($35K) on 2021-09-15, disclosed to the SEC on 2021-09-16.
Scheduled sale ($35k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.05 | 706 | $18K | 50.9% |
| 2 | $25.03 | 682 | $17K | 49.1% |
| Total | $25.04 avg | 1,388 | $35K | 100% |
| Filing → |
| ELVN | SELL | 2026-02-19 | $32K | — | Filing → |
| ELVN | SELL | 2026-01-22 | $33K | — | Filing → |
| ORIC | SELL | 2026-01-20 | $80K | — | Filing → |